Services-Misc Health & Allied Services, NEC
Standard Industrial Classification: SIC 8090
Industry Insider Sentiment Analysis
The Services-Misc Health & Allied Services, NEC sector (SIC 8090) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-28 23:04 | 2022-09-26 | AGL | Agilon Health Inc. | Kornitzer Benjamin | Officer | OPT+S | $22.86 | 16,188 | $370,043 | 10,853 |
| 2022-09-28 00:23 | 2022-09-23 | BRTX | BioRestorative Therapies, Inc. | Broadrick Dale | 10% owner | BUY | $2.83 | 300 | $849 | 298,873 |
| 2022-09-23 16:55 | 2022-09-22 | BRTX | BioRestorative Therapies, Inc. | ALSTODT LANCE | Director, Officer | BUY | $2.92 | 200 | $584 | 182,921 |
| 2022-09-16 23:12 | 2022-09-14 | PGNY | Progyny, Inc. | Payson Norman | Director | SELL | $42.14 | 13,236 | $557,760 | 365,086 |
| 2022-09-14 00:30 | 2022-09-12 | MRAI | Marpai, Inc. | Lamendola Damien | Director, 10% owner | BUY | $1.00 | 100,000 | $99,670 | 2,805,223 |
| 2022-09-12 23:10 | 2022-09-08 | AGL | Agilon Health Inc. | Kornitzer Benjamin | Officer | OPT+S | $22.82 | 21,584 | $492,467 | 10,853 |
| 2022-09-12 23:47 | 2022-09-09 | PGNY | Progyny, Inc. | Anevski Peter | Director, Officer | OPT+S | $43.08 | 4,765 | $205,299 | 122,127 |
| 2022-09-10 00:06 | 2022-09-07 | PGNY | Progyny, Inc. | Anevski Peter | Director, Officer | OPT+S | $40.60 | 75,035 | $3,046,714 | 123,080 |
| 2022-09-09 23:46 | 2022-09-07 | PGNY | Progyny, Inc. | Schlanger David J | Director, Officer | OPT+S | $39.85 | 82,633 | $3,292,702 | 82,548 |
| 2022-09-10 01:17 | 2022-08-26 | BRTX | BioRestorative Therapies, Inc. | Silva Francisco | Director, Officer | BUY | $3.28 | 5,723 | $18,777 | 12,136 |
| 2022-09-10 01:17 | 2022-08-26 | BRTX | BioRestorative Therapies, Inc. | Silva Francisco | Director, Officer | SELL | $3.39 | 3,958 | $13,410 | 158,156 |
| 2022-09-06 23:22 | 2022-09-01 | PGNY | Progyny, Inc. | Anevski Peter | Director, Officer | OPT+S | $38.98 | 20,200 | $787,451 | 138,086 |
| 2022-09-06 23:21 | 2022-09-01 | PGNY | Progyny, Inc. | Schlanger David J | Director, Officer | OPT+S | $39.01 | 42,367 | $1,652,868 | 82,548 |
| 2022-09-02 23:22 | 2022-08-31 | PGNY | Progyny, Inc. | Payson Norman | Director | SELL | $39.57 | 13,236 | $523,704 | 378,322 |
| 2022-08-25 23:10 | 2022-08-23 | AGL | Agilon Health Inc. | Kornitzer Benjamin | Officer | OPT+S | $20.69 | 10,792 | $223,327 | 10,853 |
| 2022-08-25 01:23 | 2022-08-22 | MRAI | Marpai, Inc. | Lamendola Damien | Director, 10% owner | BUY | $1.07 | 292,255 | $311,690 | 2,705,223 |
| 2022-08-20 00:42 | 2022-08-17 | MRAI | Marpai, Inc. | Lamendola Damien | Director, 10% owner | BUY | $0.86 | 250,000 | $215,850 | 2,412,968 |
| 2022-08-19 23:10 | 2022-08-17 | PGNY | Progyny, Inc. | Payson Norman | Director | SELL | $44.03 | 13,236 | $582,802 | 391,558 |
| 2022-08-19 00:30 | 2022-08-17 | MRAI | Marpai, Inc. | Kane Vincent | Director | BUY | $0.79 | 6,500 | $5,125 | 71,169 |
| 2022-08-19 01:57 | 2022-08-18 | MRAI | Marpai, Inc. | EITAN YARON | Director | BUY | $0.79 | 175,000 | $138,250 | 965,816 |
| 2022-08-18 03:01 | 2022-08-17 | MRAI | Marpai, Inc. | EITAN YARON | Director | BUY | $0.79 | 31,000 | $24,490 | 790,816 |
| 2022-08-16 23:20 | 2022-08-12 | PGNY | Progyny, Inc. | Anevski Peter | Director, Officer | OPT+S | $44.91 | 20,000 | $898,176 | 142,126 |
| 2022-08-13 00:31 | 2022-08-11 | AGL | Agilon Health Inc. | CD&R Investment Associates IX, Ltd. | 10% owner | SELL | $24.35 | 11,337,500 | $276,068,125 | 194,611,308 |
| 2022-08-12 23:16 | 2022-08-10 | PGNY | Progyny, Inc. | Schlanger David J | Director, Officer | OPT+S | $42.41 | 41,666 | $1,766,972 | 82,548 |
| 2022-08-12 23:13 | 2022-08-10 | PGNY | Progyny, Inc. | Anevski Peter | Director, Officer | OPT+S | $44.43 | 40,000 | $1,777,132 | 146,126 |
| 2022-08-10 23:52 | 2022-08-08 | PGNY | Progyny, Inc. | Anevski Peter | Director, Officer | OPT+S | $43.22 | 40,000 | $1,728,752 | 154,126 |
| 2022-08-10 23:36 | 2022-08-08 | PGNY | Progyny, Inc. | Schlanger David J | Director, Officer | OPT+S | $43.22 | 83,334 | $3,601,437 | 82,548 |
| 2022-08-08 23:30 | 2022-08-04 | AGL | Agilon Health Inc. | Kornitzer Benjamin | Officer | OPT+S | $25.02 | 16,188 | $405,072 | 10,853 |
| 2022-08-05 23:13 | 2022-08-03 | PGNY | Progyny, Inc. | Payson Norman | Director | SELL | $31.53 | 13,236 | $417,335 | 404,794 |
| 2022-07-25 23:16 | 2022-07-21 | AGL | Agilon Health Inc. | Desai Veeral | Officer | OPT+S | $27.50 | 79,768 | $2,193,620 | 278,211 |
| 2022-07-22 23:07 | 2022-07-20 | AGL | Agilon Health Inc. | Shaker Benjamin | Officer | OPT+S | $27.05 | 100,000 | $2,704,930 | 27,132 |
| 2022-07-22 23:19 | 2022-07-20 | PGNY | Progyny, Inc. | Payson Norman | Director | SELL | $33.34 | 13,236 | $441,288 | 418,030 |
| 2022-07-19 23:03 | 2022-07-15 | AGL | Agilon Health Inc. | Kornitzer Benjamin | Officer | OPT+S | $26.41 | 16,188 | $427,519 | 10,853 |
| 2022-07-15 18:46 | 2022-07-06 | BRTX | BioRestorative Therapies, Inc. | Broadrick Dale | 10% owner | BUY | $3.01 | 1,200 | $3,611 | 298,573 |
| 2022-07-13 15:25 | 2022-07-12 | BRTX | BioRestorative Therapies, Inc. | ALSTODT LANCE | Director, Officer | BUY | $2.95 | 700 | $2,065 | 182,721 |
| 2022-07-11 23:51 | 2022-07-07 | AGL | Agilon Health Inc. | Desai Veeral | Officer | OPT+S | $25.00 | 319,071 | $7,976,775 | 278,211 |
| 2022-07-08 23:34 | 2022-07-06 | PGNY | Progyny, Inc. | Payson Norman | Director | SELL | $30.11 | 13,236 | $398,525 | 431,266 |
| 2022-07-06 23:36 | 2022-07-01 | AGL | Agilon Health Inc. | Kornitzer Benjamin | Officer | OPT+S | $22.83 | 46,583 | $1,063,662 | 10,853 |
| 2022-07-06 01:10 | 2022-06-30 | BRTX | BioRestorative Therapies, Inc. | Broadrick Dale | 10% owner | BUY | $3.08 | 1,900 | $5,850 | 297,373 |
| 2022-07-01 16:20 | 2022-06-30 | BRTX | BioRestorative Therapies, Inc. | ALSTODT LANCE | Director, Officer | BUY | $3.10 | 1,100 | $3,408 | 182,021 |
| 2022-06-30 01:51 | 2022-06-27 | PGNY | Progyny, Inc. | Anevski Peter | Director, Officer | OPT+S | $31.21 | 100 | $3,121 | 162,126 |
| 2022-06-29 23:50 | 2022-06-27 | PGNY | Progyny, Inc. | Schlanger David J | Director, Officer | SELL | $31.21 | 1,452 | $45,317 | 82,548 |
| 2022-06-28 23:07 | 2022-06-24 | AGL | Agilon Health Inc. | Desai Veeral | Officer | OPT+S | $22.50 | 106,357 | $2,393,033 | 278,211 |
| 2022-06-28 02:31 | 2022-06-23 | DVA | DAVITA INC. | STAFFIERI MICHAEL DAVID | Officer | BUY | $77.70 | 20,000 | $1,554,000 | 61,190 |
| 2022-06-24 23:02 | 2022-06-22 | AGL | Agilon Health Inc. | Kornitzer Benjamin | Officer | OPT+S | $19.98 | 10,792 | $215,620 | 10,853 |
| 2022-06-24 23:18 | 2022-06-22 | PGNY | Progyny, Inc. | Payson Norman | Director | SELL | $28.05 | 13,236 | $371,321 | 444,502 |
| 2022-06-23 22:42 | 2022-06-17 | BRTX | BioRestorative Therapies, Inc. | Broadrick Dale | 10% owner | BUY | $3.79 | 700 | $2,650 | 295,473 |
| 2022-06-18 00:05 | 2022-06-15 | BRTX | BioRestorative Therapies, Inc. | Broadrick Dale | 10% owner | BUY | $3.77 | 3,200 | $12,075 | 294,773 |
| 2022-06-17 23:02 | 2022-06-16 | BRTX | BioRestorative Therapies, Inc. | ALSTODT LANCE | Director, Officer | BUY | $3.73 | 600 | $2,238 | 180,921 |
| 2022-06-16 00:50 | 2022-06-15 | BRTX | BioRestorative Therapies, Inc. | Kristal Robert Eugene | Officer | BUY | $3.61 | 194 | $700 | 7,994 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Services-Misc Health & Allied Services, NEC sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (8090) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Services-Misc Health & Allied Services, NEC
Every transaction in the Services-Misc Health & Allied Services, NEC industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.